| 000 | 01767 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515184538.0 | ||
| 264 | 0 | _c20100118 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1536-3694 | ||
| 024 | 7 |
_a10.1097/FTD.0b013e3181b1dd76 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ados Santos, Fábio Monteiro | |
| 245 | 0 | 0 |
_aPharmacokinetic/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cOct 2009 |
||
| 300 |
_a566-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 |
_aClonazepam _xadministration & dosage |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPain Threshold |
| 650 | 0 | 4 |
_aPsychomotor Disorders _xchemically induced |
| 650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
| 650 | 0 | 4 | _aReaction Time |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGonçalves, José Carlos Saraiva | |
| 700 | 1 | _aCaminha, Ricardo | |
| 700 | 1 | _ada Silveira, Gabriel Estolano | |
| 700 | 1 | _aNeves, Claúdia Silvana de Miranda | |
| 700 | 1 | _aGram, Karla Regina da Silva | |
| 700 | 1 | _aFerreira, Carla Teixeira | |
| 700 | 1 | _aJacqmin, Philippe | |
| 700 | 1 | _aNoël, François | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 31 _gno. 5 _gp. 566-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0b013e3181b1dd76 _zAvailable from publisher's website |
| 999 |
_c19130528 _d19130528 |
||